Clinical Diagnostics Technology & Disease Research News | 360Dx
360Dx covers the latest developments and trends in clinical diagnostics, including biomarkers, tests, and disease research. Find out how payor coverage, funding, and policy affect the field and its players.
About Us - 360Dx
GenomeWeb Crain Communications, Inc. 685 Third Avenue New York, NY 10017 T: 212-210-0100
Breaking News - 360Dx
Oct 28, 2024 — The deal brings the total number of CLIA-certified labs that LabGenomics has in the US to four. Last year, the firm entered the US market with the buy of QDx Pathology.
COVID-19 Diagnostics News - 360Dx
News and reporting on COVID-19 from 360Dx Diagnostics. The US Food and Drug Administration granted marketing clearances for multiple infectious disease tests and a blood culture sample preparation system, among other devices.
Diagnostics Business & Financial News - 360Dx
Oct 21, 2024 — Breaking news on diagnostics business, policy, and funding. Real-time updates on clinical labs and the in vitro diagnostics market from 360Dx.
Adaptive Biotechnologies Revenues Rise 22 Percent in Q3
16 hours ago — NEW YORK – Adaptive Biotechnologies on Thursday reported a 22 percent increase in Q3 revenues driven by an increase in minimal residual disease testing.. For the three months end ed Sept. 30, the company booked $46.4 million in total revenues, up from $37.9 million during the year-ago period and above the consensus Wall Street estimate of $40.2 million.
Genomics Research & Discovery - 360Dx
Oct 1, 2024 — The latest research news in genetics and genomics from 360Dx.
coronavirus Diagnostics News | 360Dx
Breaking news on coronavirus testing, with real-time reporting on assays to detect the SARS-CoV2 coronavirus, which causes COVID-19. Check out our Coronavirus Test Tracker for the latest information on the regulatory status of these tests in the US, European, and Asian markets.
Siemens Healthineers Reports Leaner, More Profitable Dx Business …
2 days ago — NEW YORK – Siemens Healthineers said on Wednesday that the firm's diagnostics business has become healthier, leaner, less complex, and more profitable due to a multi-year transformation as its Atellica instrument lineup is gaining ground in central labs. Jochen Schmitz, Siemens Healthineers CFO ...
Caris Life Sciences CDx Assay Nabs FDA Approval | 360Dx
1 day ago — The story has been clarified to say the assay is available for patients ages 1 and above. NEW YORK – Caris Life Sciences announced Wednesday that its MI Cancer Seek next-generation sequencing-based assay has received approval from the US Food and Drug Administration as a companion diagnostic for multiple therapies.